CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment
Clinical trial NCT05381662 · UNKNOWN
Trial details
- NCT number
- NCT05381662
- Sponsor
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2024-08-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.